期刊文献+

器官移植病人戊型肝炎病毒慢性化感染及治疗 被引量:3

Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients
原文传递
导出
摘要 戊型肝炎是由戊型肝炎病毒(Hepatitis E virus,HEV)感染引起的急性病毒性肝炎,其发病率居急性病毒性肝炎之首。戊型肝炎通常呈急性感染病程,2008年以来陆续发现器官移植病人等免疫抑制患者感染HEV后可能迁延为慢性化。在无抗病毒药物治疗的情况下,器官移植病人感染HEV后迁延为慢性感染的比例超过60%,其中10%的病人慢性感染HEV后可能出现肝纤维化,并且在较短的时间内进展为失代偿性肝硬化导致死亡。本文简要综述器官移植病人HEV慢性化感染及治疗。 Hepatitis E,caused by hepatitis E virus(HEV)infection,usually leads to an acute clinical course,and is the most common diagnosis among cases of acute viral hepatitis.From 2008,there have been increasing reports of chronic HEV infection in immunocompromised patients such as organ transplant recipients.Without intervention with antiviral treatment,approximately 60% of HEV infections in organ transplant recipients evolve into chronic HEV infections.Of these chronic hepatitis E patients,10% may develop liver fibrosis and progress to liver cirrhosis.This article reviews chronic HEV infection and treatment in organ transplant recipients.
出处 《病毒学报》 CAS CSCD 北大核心 2015年第3期293-298,共6页 Chinese Journal of Virology
基金 国家科技重大专项(2013ZX09101017) 国家自然科学基金(81373061) 厦门市科技计划项目(3502Z20131001)
关键词 戊型肝炎病毒 器官移植 慢性化感染 治疗 Hepatitis E virus Organ transplant Chronic infection Treatment
  • 相关文献

参考文献54

  • 1Reyes G R,Purdy M A,Kim J P,Luk K C,Young L M,Fry K E,Bradley D W.Isolation of a cDNA from the virus responsible for enterically transmitted non-A,non-B hepatitis[J].Science,1990,247(4948):1335-1339.
  • 2中国疾病预防控制中心.全国传染病疫情概况[M].http://www.chinacdc.cn/.
  • 3Purcell R H,Emerson S U.Hepatitis E:an emerging awareness of an old disease[J].J Hepatol,2008,48(3):494-503.
  • 4WHO Fact sheet,Hepatitis E[N] ,Updated June,2014.
  • 5Navaneethan U,Al Mohajer M,Shata M T.Hepatitis E and pregnancy:understanding the pathogenesis[J].Liver Int,2008,28(9):1190-1199.
  • 6Kumar Acharya S,Kumar Sharma P,Singh R,Kumar Mohanty S,Madan K,Kumar Jha J,Kumar Panda S.Hepatitis E virus(HEV)infection in patients with cirrhosis is associated with rapid decompensation and death[J].J Hepatol,2007,46(3):387-394.
  • 7Emerson S U,Purcell R H.Hepatitis E virus[J].Rev Med Virol,2003,13(3):145-154.
  • 8AST.The American Society of Transplantation Infectious Diseases Guidelines 3rd Edition[M].2013.
  • 9Green M.Introduction:Infections in solid organ transplantation[J].Am J Transplant,2013,13Suppl 4:3-8.
  • 10Kamar N,Selves J,Mansuy J M,Ouezzani L,Peron J M,Guitard J,Cointault O,Esposito L,Abravanel F,Danjoux M,Durand D,Vinel J P,Izopet J,Rostaing L.Hepatitis E virus and chronic hepatitis in organtransplant recipients[J].N Engl J Med,2008,358(8):811-817.

共引文献1879

同被引文献33

  • 1Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT; HIV-TR Investigators. Hepatitis E infection in HIV- infected liver and kidney transplant candidates [J]. J Viral Hepat, 2014, 21(8).. e74-e77.
  • 2Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters MG, Seaberg EC, Chen Y, Nelson KE, Linnen JM. Acute and chronic hepatitis E virus infection in HIV-infected U.S. women [J]. Hepatology, 2016, 63(3): 712-720.
  • 3Geng Y, Zhao C, Huang W, Harrison TJ, Zhang H, Geng K, Wang Y. Detection and assessment of infectivity of hepatitis E virus in urine [J]. J Hepatol, 2016, 64(1): 37-43.
  • 4Geng , Zhang H, Huang W, Harrison TJ, Geng K, Li Z, Wang Y. Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia E J/OLd. Hepat Mon, 2014. http://www, ncbi. nlm. nih. gov/pmc/ articles/PMC3929864.
  • 5Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy [J]- Semin Liver Dis, 2013, 33(1): 62-70.
  • 6Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, Petrik J. Hepatitis E virus in Scottish blood donors [J]. Vox Sang, 2013, 105(4).. 283-289.
  • 7Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M, Liu XH, Li JX, Yang CL, Tang Q, Jiang RJ, Pan HR, Li YM, Shih JW, Ng MH, Zhu FC, Xia NS. Long-term efficacy of a hepatitis E vaccine [J]. N Engl J Med, 2015, 372(10) .. 914- 922.
  • 8Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults, a large-scale, randomised, double-blind placebo- controlled, phase 3 trial [J]. Lancet, 2010, 376 (9744) 895-902.
  • 9Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity [J]. Rev Med Virol, 2012, 22 (5): 339-349.
  • 10WHO. Hepatitis E vaccine: WHO position paper, May 2015 [J]. Wkly Epidemiol Rec, 2015, 90(18): 185-200.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部